Related Experiment Videos
Update on rilmenidine: clinical benefits.
1Department of Medicine and Therapeutics, University of Glasgow, Scotland.
American Journal of Hypertension
|November 28, 2001
Summary
Rilmenidine effectively lowers blood pressure and offers metabolic benefits, potentially reducing long-term cardiovascular risk. This antihypertensive agent is well-tolerated and shows promise in cardiovascular disease prevention.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Rilmenidine is an imidazoline derivative used for hypertension.
- Its mechanism involves imidazoline (I1) receptors in the brainstem and kidneys.
- Established antihypertensives include diuretics, beta-blockers, ACE inhibitors, and calcium antagonists.
Purpose of the Study:
- To evaluate the efficacy and tolerability of rilmenidine as an antihypertensive therapy.
- To investigate the potential of rilmenidine in improving metabolic factors and reducing cardiovascular risk.
- To assess rilmenidine's effects on cardiac and renal parameters.
Main Methods:
- Clinical evaluation of rilmenidine's blood pressure-lowering effects.
- Assessment of its tolerability and side effect profile.
- Analysis of its impact on glucose tolerance, lipid profiles, insulin sensitivity, left ventricular hypertrophy, and microalbuminuria.
Main Results:
- Rilmenidine demonstrates efficacy comparable to first-line antihypertensive drugs in monotherapy.
- It is well-tolerated, with minimal sedation or dry mouth, and no withdrawal hypertension.
- Rilmenidine improves glucose tolerance, lipid risk factors, and insulin sensitivity.
- It also shows beneficial effects on the heart (reducing left ventricular hypertrophy) and kidneys (reducing microalbuminuria).
Conclusions:
- Rilmenidine is an effective and well-tolerated antihypertensive agent.
- It offers potential cardiovascular benefits beyond blood pressure reduction by improving metabolic parameters and organ protection.
- While long-term outcome data are pending, rilmenidine represents a promising development in managing hypertension and preventing cardiovascular disease.